Fungal vaccines: real progress from real challenges

被引:84
作者
Cassone, Antonio [1 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
关键词
D O I
10.1016/S1473-3099(08)70016-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Among viral, bacterial, and fungal diseases, the latter are the only branch of infectious diseases without a vaccine for any of their causative agents. This is at odds with a disease burden that remains unabated by conventional chemotherapy and infection control measures. Since most fungal infections occur in immunocompromised patients, the generation of tools relying on host immunity for effectiveness is a notable challenge. Nevertheless, with improved knowledge of the host-fungus relation, and the spectacular advances in genome sequencing, genetic engineering, and proteomics, strong progress in fungal vaccine research is being made. Some vaccines induce the generation of directly fungicidal antibodies; others are protective in animals carrying major risk factors for fungal infections, such as CD4+ T-cell-deficiency or neutropenia. Together with the demonstrated efficacy of various antibodies in passive vaccination approaches, there is growing confidence in the future availability of safe and efficacious immunological tools to combat deadly microbes in a weak host.
引用
收藏
页码:114 / 124
页数:11
相关论文
共 138 条
[1]   Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo [J].
Accapezzato, D ;
Visco, V ;
Francavilla, V ;
Molette, C ;
Donato, T ;
Paroli, M ;
Mondelli, MU ;
Doria, M ;
Torrisi, MR ;
Barnaba, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :817-828
[2]   Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells [J].
Acosta-Rodriguez, Eva V. ;
Rivino, Laura ;
Geginat, Jens ;
Jarrossay, David ;
Gattorno, Marco ;
Lanzavecchia, Antonio ;
Sallusto, Federica ;
Napolitani, Giorgio .
NATURE IMMUNOLOGY, 2007, 8 (06) :639-646
[3]   Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation [J].
Bacci, A ;
Montagnoli, C ;
Perruccio, K ;
Bozza, S ;
Gaziano, R ;
Pitzurra, L ;
Velardi, A ;
d'Ostiani, CF ;
Cutler, JE ;
Romani, L .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :2904-2913
[4]   Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection [J].
Beenhouwer, David O. ;
Yoo, Esther M. ;
Lai, Chun-Wei ;
Rocha, Miguel A. ;
Morrison, Sherie L. .
INFECTION AND IMMUNITY, 2007, 75 (03) :1424-1435
[5]   Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria [J].
Beninati, C ;
Oggioni, MR ;
Boccanera, M ;
Spinosa, MR ;
Maggi, T ;
Conti, S ;
Magliani, W ;
De Bernardis, F ;
Teti, G ;
Cassone, A ;
Pozzi, G ;
Polonelli, L .
NATURE BIOTECHNOLOGY, 2000, 18 (10) :1060-1064
[6]   EVIDENCE FOR MACROPHAGE-MEDIATED PROTECTION AGAINST LETHAL CANDIDA-ALBICANS INFECTION [J].
BISTONI, F ;
VECCHIARELLI, A ;
CENCI, E ;
PUCCETTI, P ;
MARCONI, P ;
CASSONE, A .
INFECTION AND IMMUNITY, 1986, 51 (02) :668-674
[7]   Managing infections in the immunocompromised patient [J].
Bodey, GP .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S239-S239
[8]   Dendritic cell-based vaccination against opportunistic fungi [J].
Bozza, S ;
Montagnoli, C ;
Gaziano, R ;
Rossi, G ;
Nkwanyuo, G ;
Bellocchio, S ;
Romani, L .
VACCINE, 2004, 22 (07) :857-864
[9]   Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants [J].
Bozza, S ;
Gaziano, R ;
Lipford, GB ;
Montagnoli, C ;
Bacci, A ;
Di Francesco, P ;
Kurup, VP ;
Wagner, H ;
Romani, L .
MICROBES AND INFECTION, 2002, 4 (13) :1281-1290
[10]   Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine [J].
Bromuro, C ;
Torosantucci, A ;
Chiani, P ;
Conti, S ;
Polonelli, L ;
Cassone, A .
INFECTION AND IMMUNITY, 2002, 70 (10) :5462-5470